Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

CRBP – Corbus Pharmaceuticals Holdings, Inc.

Corbus Pharmaceuticals Holdings
CRBP
$14.52
Name : Corbus Pharmaceuticals Holdings
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $177,945,872.00
EPSttm : -4.76
finviz dynamic chart for CRBP
Corbus Pharmaceuticals Holdings
$14.52
2.09%
$0.31

Float Short %

10.88

Margin Of Safety %

Put/Call OI Ratio

0.23

EPS Next Q Diff

-0.13

EPS Last/This Y

-2.74

EPS This/Next Y

1.16

Price

14.5

Target Price

40.67

Analyst Recom

1

Performance Q

92.57

Relative Volume

1.29

Beta

2.7

Ticker: CRBP




20 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-09-08CRBP9.890.270.072929
2025-09-09CRBP9.530.270.002942
2025-09-10CRBP9.660.260.243026
2025-09-11CRBP9.50.260.003049
2025-09-12CRBP9.490.260.003070
2025-09-15CRBP9.350.260.013070
2025-09-16CRBP10.310.240.033328
2025-09-17CRBP11.620.215784215784220.00561797752808993651
2025-09-18CRBP11.620.196.004097
2025-09-22CRBP11.580.060.042113
2025-09-23CRBP11.530.050.003497
2025-09-24CRBP11.510.030.005482
2025-09-25CRBP12.110.030.005898
2025-09-26CRBP12.050.030.035975
2025-09-29CRBP12.260.030.005967
2025-09-30CRBP12.760.0386.296077
2025-10-01CRBP13.030.230.057292
2025-10-02CRBP13.010.230.097353
2025-10-03CRBP14.820.230.107390
2025-10-06CRBP14.50.230.377471
DateSymbolLastP/C OIP/C VolTotal OI
20 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-09-08CRBP9.89-33.3-27.9-5.63
2025-09-09CRBP9.62-33.310.5-5.63
2025-09-10CRBP9.62-33.3-49.4-5.63
2025-09-11CRBP9.50-33.314.2-5.63
2025-09-12CRBP9.50-33.3-24.5-5.63
2025-09-15CRBP9.32-33.363.0-5.63
2025-09-16CRBP10.27-33.3-1364.5-5.63
2025-09-17CRBP11.61-33.3-152.5-5.63
2025-09-18CRBP11.59-33.3-29.0-5.63
2025-09-19CRBP11.50-33.3-26.9-5.63
2025-09-22CRBP11.56-33.3-32.2-5.63
2025-09-23CRBP11.55-33.3-30.3-5.63
2025-09-24CRBP11.51-33.3-30.3-5.63
2025-09-25CRBP12.14-33.3-57.5-5.63
2025-09-26CRBP12.11-33.3-29.8-5.70
2025-09-29CRBP12.31-48.4-38.0-6.39
2025-09-30CRBP12.74-48.4-46.8-6.39
2025-10-01CRBP13.03-48.4-40.6-6.39
2025-10-02CRBP13.02-48.4-30.3-6.39
2025-10-03CRBP14.80-48.4-75.2-6.42
2025-10-06CRBP14.50-48.4-67.5-6.42
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-09-08CRBP-0.27-20.6311.32
2025-09-09CRBP-0.27-20.6311.32
2025-09-10CRBP-0.27-20.6311.32
2025-09-11CRBP-0.27-20.6310.84
2025-09-12CRBP-0.27-20.6310.84
2025-09-15CRBP-0.27-20.4710.84
2025-09-16CRBP-0.27-20.4710.84
2025-09-17CRBP-0.27-20.4710.84
2025-09-18CRBP-0.27-20.4710.84
2025-09-19CRBP-0.27-20.4710.84
2025-09-22CRBP-0.27-20.4810.84
2025-09-23CRBP-0.27-20.4810.84
2025-09-24CRBP-0.27-20.4810.84
2025-09-25CRBP-0.27-20.4811.17
2025-09-26CRBP-0.27-20.4811.17
2025-09-29CRBP-0.27-20.4910.88
2025-09-30CRBP-0.33-20.4910.88
2025-10-01CRBP-0.33-20.4910.88
2025-10-02CRBP-0.33-20.4910.88
2025-10-03CRBP-0.33-20.4910.88
2025-10-06CRBP-0.33-10.5410.88
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

-1.44

Avg. EPS Est. Current Quarter

-1.71

Avg. EPS Est. Next Quarter

-1.57

Insider Transactions

-0.33

Institutional Transactions

-10.54

Beta

2.7

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

1

Fair Value

Quality Score

14

Growth Score

23

Sentiment Score

58

Actual DrawDown %

87.9

Max Drawdown 5-Year %

-97.9

Target Price

40.67

P/E

Forward P/E

PEG

P/S

P/B

1.6

P/Free Cash Flow

EPS

-4.76

Average EPS Est. Cur. Y​

-6.42

EPS Next Y. (Est.)

-5.26

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

1.29

Return on Equity vs Sector %

-77.3

Return on Equity vs Industry %

-63.7

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.02

EBIT Estimation

-67.5
Corbus Pharmaceuticals Holdings
Sector: Healthcare
Industry: Biotechnology
Employees: 28
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, develops products to defeat serious illness. It develops CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E (MMAE), which is in Phase I clinical trial; CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFß expressed on cancer cells for the treatment of solid tumors; CRB-913, a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. It has a licensing agreement with Jenrin Discovery, LLC to develop and commercialize the licensed products, including the Jenrin library of approximately 600 compounds, and multiple issued and pending patent filings. The company was incorporated in 2009 and is based in Norwood, Massachusetts.
stock quote shares CRBP – Corbus Pharmaceuticals Holdings, Inc. Stock Price stock today
news today CRBP – Corbus Pharmaceuticals Holdings, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch CRBP – Corbus Pharmaceuticals Holdings, Inc. yahoo finance google finance
stock history CRBP – Corbus Pharmaceuticals Holdings, Inc. invest stock market
stock prices CRBP premarket after hours
ticker CRBP fair value insiders trading